Thrilled to see the ASTRO HPV-positive oropharyngeal cancer guideline out in PRO! practicalradonc.org/article/S1879-…

Tremendous kudos to the incredible ASTRO guideline staff (Lisa Bradfield & Amanda Helms), guideline subcommittee, peer/public reviewers, and the tireless, insightful and deeply collegial expert panel, including the incomparable @danimargalit.

@ankeruvmradonc @musjawan Gopal K. Bajaj, MD, MBA, FASTRO @califanomd @jjcaudell @christinachapmd Alexander Lin @elliemaghamimd RaneeMehra Lisa Shnayder, MD C. Jillian Tsai, MD, PhD

Robert Ferris (Robert Ferris, MD, PhD), MD, PhD, named executive director of UNC Lineberger, and UNC system chief of oncology services, effective October 1st, announced UNC School of Medicine Dean Wesley Burks, MD. UNC Health unclineberger.org/news/robert-fe…

I am honored and excited to join UNC Lineberger and UNC health, to make an impact across the Triangle and state of NC, reducing the burden of cancer and advancing research and cancer treatment! Amazing team and strong legacy of directors Earp, Sharpless and Pagano.

It’s worse than bad news.

Everyone is invited to Denver for a fantastic all-you-need-to-know session on toxicities affecting head and neck cancer patients. This will be on THURSDAY WITH LUNCH. Please come mingle with our incredible clinician PIs from NRG Oncology - and stay Friday! We have a lot to talk about!

It's been a privilege working with our fellows Drs. Sara Mheid and Daphne Valmonte of The Allan & Ruth Kerbel Palliative Radiotherapy and Oligomet Program (PROP) Princess Margaret Cancer Centre Radiation Medicine Program Radiation Oncology. Special thanks to Dr. Bernard Cummings for his longstanding dedication and

I enjoyed reading the new advancements in NSCLC, in sharp contrast to HNSCC... Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC | New England Journal of Medicine nejm.org/doi/full/10.10…

A very thoughtful opinion piece by Nancy Lee Memorial Sloan Kettering Radiation Oncology Lực Morris Max Diehn, MD/PhD outlining the caveats of using TTMV-HPV DNA as a routine biomarker for surveillance and treatment decision-making. Given the lack of robust sensitivity, such application should be carried out in

🚨Hey #radonc! 🚨 Ever wonder which #ASTRO journal you should submit your manuscript to? Same. My colleague Dr. Kilian Salerno just shared this figure with me to help! Happy publishing!

🚨📸HN Rad Oncs - would you change your ADJ RT practice for INT RISK (close margin, < 1mm ENE, 2-4LN, +PNI/LVSI) HPV+OPC after ECOG 3311 long-term results after #ASCO24. Assuming no other de-escalation protocol available? (Had to redo the vote due to poor wording/choices 😃)

🚨📷 (1/3) Another series of polls for HN Rad Oncs since we are trying to modify/unify our practice here: What is your margin from GTVprimary to CTVprimary (CTV1)? Melvin LK CHUA Dr. David Palma David Sher Sana Karam, MD, PhD James Bates Christina Chapman, M.D., M.S. Christina Henson, MD Scott Bratman Daniel Ma

🚨📷 (2/3) Another series of polls for HN Rad Oncs since we are trying to modify/unify our practice here: What is your margin from GTVprimary_high_dose to CTVprimary_intermediate_dose (CTV2)? (eg. GTV70Gy to CTV30-50Gy) Melvin LK CHUA Dr. David Palma David Sher Sana Karam, MD, PhD

🚨📷 (3/3) Another series of polls for HN Rad Oncs since we are trying to modify/unify our practice here: What is your margin from CTVprimary_intermediate_dose to PTVprimary_intermediate_dose? (eg. CTV30-50Gy to PTV30-50Gy) Melvin LK CHUA Dr. David Palma David Sher Sana Karam, MD, PhD

FLASHBACK Barbara Bush: "I don’t know how women can vote" for Donald Trump. #RepublicansForHarris #NeverTrump

Algerian boxer Imane Khelif called for an end to bullying athletes after she faced a wave of online abuse over misconceptions about her gender during the Paris Olympics.

I had the honor of visiting Princess Margaret Cancer Centre last week as a part of their summer series on AI/ML. Sharing insights on how #VirtualReality and AR can transform radonc training (and beyond) was a fantastic experience! Grateful for the opportunity to connect with such a

🛑🛑🛑Here is our STOP RCT looking at SABR in patients with oligoprogressive cancers, just published in @ijrobp www-redjournal-org.proxy1.lib.uwo.ca/article/S0360-… We learned a few important lessons for clinical practice and for the design of future trials...(thread 👇)